FDA doesn't see increased risk of stroke for seniors who received Pfizer's omicron booster
Publishing timestamp: 2023-01-26 13:35:47
Summary
The FDA has conducted an extensive review of federal data and reached out to international regulators and Pfizer to investigate the possibility of stroke risk in seniors who received Pfizer's omicron booster shot. The review did not find any increased risk of stroke, but the FDA is launching a study to look into the potential safety concerns of administering the Covid omicron shots at the same time as high-dose or adjuvant flu shots.
Sentiment: NEUTRAL
Tickers: PFE,
Keywords: epidemics, business, pandemics, disease outbreaks, biotechnology, biotech and pharmaceuticals, u.s. economy, health care industry, coronavirus, business news, breaking news: business, politics, pfizer inc,